This conference call transcript was computer generated and almost certianly contains errors. This transcript is provided for information purposes only.EarningsCall, LLC makes no representation about the accuracy of the aforementioned transcript, and you are cautioned not to place undue reliance on the information provided by the transcript.

Diversified Healthcare Trust
11/3/2026
Good morning and welcome to the Diversified Healthcare Trust third quarter 2026 earnings conference call. All participants will be in listen-only mode. Should you need assistance, please signal a conference specialist by pressing the star key followed by zero. After today's presentation, there will be an opportunity to ask questions. To ask a question, you may press star then one on your telephone keypad. To withdraw your question, please press star, then two. Please note, this event is being recorded. I would now like to turn the conference over to Matthew Murphy, Manager of Investor Relations. Please go ahead.
Good morning. Joining me on today's call are Chris Bilotto, President and Chief Executive Officer, and Matt Brown, Chief Financial Officer and Treasurer. Today's call includes a presentation by management followed by a question and answer session with sell-side analysts. Please note that the recording and retransmission of today's conference call is strictly prohibited without the prior written consent of the company. Today's conference call contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 and other securities laws. These forward-looking statements are based upon DHC's beliefs and expectations. as of today, Tuesday, November 3rd, 2026. The company undertakes no obligation to revise or publicly release the results of any revision to the forward-looking statements made in today's conference call, other than through filings with the Securities and Exchange Commission or SEC. Actual results may differ materially from those projected in any forward-looking statements. additional information concerning factors that could cause those differences is contained in our filings with the SEC. Investors are cautioned not to place undue reliance upon any forward-looking statements. In addition, this call may contain non-GAAP numbers, including normalized funds from operations or normalized FFO, Net Operating Income, or NOI, Cash Basis Net Operating Income, or Cash Basis NOI, and Adjusted EBITDA RE. A reconciliation of these non-GAAP measures to net income is available in our financial results package, which can be found on our website at www.dhcrete.com. Beginning this quarter, our calculations of normalized SFO and adjusted EBITDA RE include estimated incentive management fees accrued under GAAP, and prior periods have been recast to conform to this presentation. And finally, we will be providing guidance on this call, including NLI. We are not providing a reconciliation of these non-GAAP measures as part of our guidance because certain information required for such reconciliation is not available without unreasonable efforts or at all, such as gains and losses or impairment charges related to the disposition of real estate. With that, I would now like to turn the call over to Chris.
Thank you, Matt. Good morning, everyone, and thank you for joining our call today. Our third quarter results reflect continued execution on the strategy we have laid out for the year. That strategy shows up across stronger operating results in our shop portfolio, active optimization of how we own and operate individual assets, and a steadily improving financial profile. Following the market close yesterday, DHC reported normalized FFO of $30.7 million, or 13 cents per share, and adjusted EBITDA RE of $73.4 million, and increase of 28.4% year over year. Same property cash basis NOI increased 25.6% to $77.9 million and consolidated NOI increased 27.5% to $80.8 million. Before going further, I want to note a change in our presentation. Beginning this quarter, adjusted EBITDA RE and normalized FFO include incentive management fees as recognized under GAAP and prior periods have been recast on the same basis. On that comparable basis, normalized FFO increased from 12 cents per share in the second quarter and from 2 cents per share a year ago and adjusted EBITDA increased both sequentially and year over year. The momentum in our portfolio is also reflected in our outlook. Today we are raising our same property shop NOI guidance by $5 million at the midpoint and Loring are expected shop recurring capital expenditures by $10 million. Matt will walk through the full guidance update, including the effect of the incentive management fee change. Let me start with our shop segment. Same property NOI increased 50.4% year over year to $48 million. This growth was driven by a 200 basis point increase in occupancy to 84.4% and a 5.2% increase in average monthly rate which together expand the same property NOI margin by 470 basis points at 15.8%. We use targeted move-in incentives this quarter to accelerate occupancy, which kept average monthly rate flat sequentially. As communities stabilize, we expect to reduce these concessions and allow rate growth to flow through more fully. Expense discipline also continues with our dietary procurement initiatives, contributing to an expense reduction by approximately $1.3 million compared with the prior year. Importantly, we believe significant embedded upside remains. With same property occupancy at 84.4%, we estimate 500 to 600 basis points of occupancy upside as our operators close the occupancy gaps between our communities and the respective NIC markets. Beyond occupancy, we continue to reposition underutilized and closed skilled nursing wings into independent living, assisted living, and memory care units. We have now approved projects across 13 communities that we expect will add approximately 356 units. We expect these investments to generate stabilized cash returns in the mid-teens or better while converting vacant space into revenue generating units. Finally, we are putting new management agreements in place across 76 shop communities that are managed by our legacy operators. Implementation is expected on January 1st, 2027. These agreements extend the operator framework we initiated across our transition community to 2025, including more closely aligned incentive structures and appropriately sized base management fees. We expect them to initially generate approximately $2 million of annual cost savings while further aligning operator incentives with shareholder interests. Turning to our portfolio optimization strategy. Over the past two years, DHC has repositioned its portfolio through asset sales, operator transitions, and targeted capital investments. with much of that foundation in place, we are increasingly focused on optimizing individual assets. The clearest example this quarter is our transition of seven skilled nursing facilities in Colorado to a 15-year triple net lease with the Ensign Group, effective on October 1st. This transition does two primary things for us. First, it increases cash flow. First-year contractual rent is approximately $8 million with CPI annual escalators which compares with 5.1 million of NOI over the prior 12 months or about 3.5 million after capital expenditures. Second, it sharpens our shop portfolio. Skilled nursing relies primarily on government reimbursement and is a more labor intensive which is why these facilities generated only about a 5.8% margin for the quarter. Skilled nursing is also more commonly under triple net leases with specialized operators. The new structure shifts reimbursement, labor and capital exposure to the tenant leaves our shop portfolio more focused on private pay senior housing and on a pro forma basis would have lifted our third quarter consolidated shop margin by about 80 basis points. We are applying the same asset by asset approach to operator alignment. In September, we provided notice to transition six shop communities in Georgia representing 486 units to a new manager, which we expect to begin as early as the fourth quarter. This consolidates these communities with an operator that has deep regional expertise and fits the operator framework we have built across our transition portfolio. We look forward to working closely with them to ensure a seamless transition. Turning to our medical office and life science portfolio, leasing activity remained healthy during the quarter. We completed approximately 130,000 square feet of leasing at rental rates 25% above prior rents with a weighted average lease term of 9.7 years. As discussed on our second quarter earnings call, two tenants representing approximately 213,000 square feet vacated on July 1st, and total occupancy declined to 88.4% from 92.2% in the prior quarter. Near-term expirations are limited. Through year-end, $3.3 million of annualized rental income, or 2.1% of the total, is scheduled to expire. This includes $2.2 million from a life science tenant in Fremont, California that we expect to vacate at the end of November, and we are actively marketing that space for lease. The portfolio's weighted average remaining lease term was approximately 5.1 years at quarter end. As part of our capital and recycling efforts, we are actively pursuing disposition opportunities. As of yesterday, we were under agreement to sell one vacant property consisting 126,000 square feet for $10.5 million, and we are valuing offers on two additional properties totaling approximately 232,000 square feet. Together, these three properties generated negative NOI of $690,000 during the quarter or nearly $2.8 million annually. Selling them eliminates that drag and provides capital for reinvestment. Looking ahead, our path to earnings growth is embedded in our existing portfolio. Several drivers are already in motion for 2027. A full year rent from the enzyme lease, approximately $2 million of annual savings from our new shop legacy management agreements effective January 1st, skilled nursing ROI conversion projects, adding approximately 350 units, and the sale of non-earning medical office properties. Most significant is the continued improvement in shop occupancy and rate concessions as rate concessions normalize. Our third quarter results show this strategy is working with stronger shop operations, active optimization of individual assets, and improving financial profile and a higher shop NOI outlook for the year. These results are clearly resonating with investors as DHC has been the top performing rate in the U.S. over the past three years with a total shareholder return in excess of 277%. We remain confident in our trajectory and in our ability to deliver sustainable earnings growth and long-term value for our shareholders. With that, I'll turn the call over to Matt.
You're reading a preview of the DHC Q3 2026 earnings call.
Free account.
Want transcripts like this in your own app? Try the Earnings call API, or read the transcript API docs.
Use this data in your own app
Pull this call's transcript, audio and slides with the Earnings call transcripts API.
See pricing